Pfizer beats fourth-quarter profit estimates on strong drug demand

Core Insights - Pfizer reported fourth-quarter profit exceeding Wall Street estimates, driven by sustained demand for older drugs like blood thinner Eliquis, which helped mitigate declining sales from COVID-related products [1] Financial Performance - The company’s fourth-quarter profit was above expectations, indicating strong performance in its traditional drug portfolio despite challenges in the COVID product segment [1]